Bsbe

BSBE is a Chinese leading provider of in-vitro diagnostics (IVD) products and service, there are biochemistry reagents, coaguation reagents and instrument, blood grouping cards and instrument, etc. BSBE was established in 2001, focusing on R&D, manufacturing and sales of IVD products which reach to international advanced level. BSBE was registered in Beijing, the capital of China with the registered capital of RMB501,787,943 and successfully listed on GEM in Shenzhen with the stock code 300406 in 2014. As a Chinese leader in IVD filed, BSBE is engaged in developing the best IVD testing platform. And till now, BSBE has the system of clinical biochemistry testing, coagulation testing and blood typing. Due to the steady progression and rich experience in the years, BSBE has a worldwide sales and marketing network. BSBE is focused on the R&D of IVD products and it has a high qualified R&D team. Under the guidance of the experts, BSBE has established clinical biochemistry platform of enzymatic method (including enzymatic cycling method), immunoturbidimetric method, latex immunoturbidimetric method, CEDIA method, EMIT method; Meanwhile, BSBE has very strong R&D team on liquid coagulation reagents. In 2018, BSBE launches its blood typing system using the DG Gel card technology.